Malignant Melanoma Clinical Trials in Jerusalem
2 recruitingJerusalem, Israel
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Malignant Melanoma
Merck Sharp & Dohme LLC160 enrolled38 locationsNCT06961006
Recruiting
Phase 1Phase 2
Modified Vaccine for High Risk or Low Residual Melanoma Patients
Malignant Melanoma
Hadassah Medical Organization50 enrolled1 locationNCT01898039